BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24572417)

  • 1. Tuberculosis: Drug discovery goes au naturel.
    Barry CE
    Nature; 2014 Feb; 506(7489):436-7. PubMed ID: 24572417
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-resistant tuberculosis: a new shot on goal.
    Nathan C
    Nat Med; 2014 Feb; 20(2):121-3. PubMed ID: 24504402
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibacterial drugs: Redesigned antibiotic combats drug-resistant tuberculosis.
    Cully M
    Nat Rev Drug Discov; 2014 Apr; 13(4):256. PubMed ID: 24658308
    [No Abstract]   [Full Text] [Related]  

  • 4. Spectinamides: a challenge, a proof, and a suggestion.
    Viveiros M; Pieroni M
    Trends Microbiol; 2014 Apr; 22(4):170-1. PubMed ID: 24636244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux.
    Lee RE; Hurdle JG; Liu J; Bruhn DF; Matt T; Scherman MS; Vaddady PK; Zheng Z; Qi J; Akbergenov R; Das S; Madhura DB; Rathi C; Trivedi A; Villellas C; Lee RB; Rakesh ; Waidyarachchi SL; Sun D; McNeil MR; Ainsa JA; Boshoff HI; Gonzalez-Juarrero M; Meibohm B; Böttger EC; Lenaerts AJ
    Nat Med; 2014 Feb; 20(2):152-158. PubMed ID: 24464186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
    Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Dusthackeer VNA; Rode HB
    Eur J Med Chem; 2019 Feb; 164():665-677. PubMed ID: 30654238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
    Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
    Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new era for treatment of drug-resistant tuberculosis.
    Gandhi NR; Brust JCM; Shah NS
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30287493
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluoroquinolone resistance in multidrug-resistant
    Che Y; Song Q; Yang T; Ping G; Yu M
    Eur Respir J; 2017 Dec; 50(6):. PubMed ID: 29217603
    [No Abstract]   [Full Text] [Related]  

  • 10. Nomenclature of drug-resistant tuberculosis.
    Udwadia ZF; Amale RA; Ajbani KK; Rodrigues CS
    Lancet Infect Dis; 2013 Nov; 13(11):917. PubMed ID: 24156895
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuberculosis susceptibility--implications for drug development and therapy.
    Snell NJ
    Expert Opin Pharmacother; 2003 Sep; 4(9):1455-60. PubMed ID: 12943474
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis.
    Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Azger Dusthackeer VN; Rode HB
    Future Med Chem; 2019 Mar; 11(6):499-510. PubMed ID: 30892944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in chemotherapy of multidrug-resistant and rifampicin-resistant tuberculosis].
    Liu SS; Wang LZ; Tang SJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):371-375. PubMed ID: 32294820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant tuberculosis: reality and potential threat.
    Lalloo UG
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in Vivo.
    Vickers CF; Silva APG; Chakraborty A; Fernandez P; Kurepina N; Saville C; Naranjo Y; Pons M; Schnettger LS; Gutierrez MG; Park S; Kreiswith BN; Perlin DS; Thomas EJ; Cavet JS; Tabernero L
    J Med Chem; 2018 Sep; 61(18):8337-8352. PubMed ID: 30153005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of studies on antitubercular drug resistance].
    Valenzuela P
    Rev Panam Salud Publica; 1997 Jan; 1(1):62-7. PubMed ID: 9162582
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistant tuberculosis: problems on the horizon.
    Ormerod LP
    Thorax; 1993 Oct; 48(10):957-8. PubMed ID: 8256241
    [No Abstract]   [Full Text] [Related]  

  • 18. Tuberculosis chemotherapy: recent developments and future perspectives.
    Bhowruth V; Dover LG; Besra GS
    Prog Med Chem; 2007; 45():169-203. PubMed ID: 17280904
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-resistant tuberculosis.
    Böttger EC
    Lancet; 2001 Apr; 357(9264):1288-9. PubMed ID: 11421208
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].
    Tungusova OS; Mar'iandyshev AO
    Probl Tuberk; 2001; (6):48-9. PubMed ID: 11641963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.